Global Markets for Blood Plasma Products

Table of Contents

Chapter 1 Introduction

Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Intended Audience
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports

Chapter 2 Summary and Highlights

Chapter 3 Market and Technology Background

Introduction to Blood Plasma Products
Components of Blood Plasma
Functions of Blood Plasma
Blood Donation

• Collection and Extraction of Blood Plasma
• Fractionation Methods for Extracting Individual Components from Plasma

Government Funding of Blood Donation Facilities
Government Regulations: FDA, International Regulatory Agencies and Medical Associations
Clinical Guidelines
Technology Trends
Market Dynamics

• Drivers
• Restraints
• Opportunities

Chapter 4 Market Breakdown by Product Type

Overall Market Size and Forecast
Immunoglobulins

• Market Size and Forecast by Region
• Market Size and Forecast by Subsegment

Albumin

• Market Size and Forecast by Region

Coagulation Factor Concentrates

• Market Size and Forecast by Region

Hyperimmune Globulin

• Market Size and Forecast by Region

Other Plasma Fractionation Products

• Market Size and Forecast by Region

Chapter 5 Market Breakdown by Application

Overall Market Size and Forecast
Neurology

• Market Size and Forecast by Region

Immunology

• Market Size and Forecast by Region

Oncology

• Market Size and Forecast by Region

Transplants

• Market Size and Forecast by Region

Hematology

• Market Size and Forecast by Region

Rheumatology

• Market Size and Forecast by Region

Pulmonology

• Market Size and Forecast by Region

Others

• Market Size and Forecast by Region

Chapter 6 Market Breakdown by End User

Overall Market Size and Forecast
Hospitals and Clinics

• Market Size and Forecast by Region

Research Laboratories

• Market Size and Forecast by Region

Academic Institutions

• Market Size and Forecast by Region

Blood Transfusion Centers

• Market Size and Forecast by Region

Chapter 7 Mode of Delivery for Blood Plasma

Infusion Solutions
Gels
Sprays
Biomedical Sealants

Chapter 8 Market Breakdown by Region

Overall Market Size and Forecast by Region
North America

• U.S. Market Size and Forecast
• Canadian Market Size and Forecast
• Mexican Market Size and Forecast
• Market Size and Forecast by Product Type
• Market Size and Forecast by Application
• Market Size and Forecast by End User

Europe

• German Market Size and Forecast
• French Market Size and Forecast
• Italian Market Size and Forecast
• Spanish Market Size and Forecast
• U.K. Market Size and Forecast
• Rest of Europe Market Size and Forecast
• Market Size and Forecast by Product Type
• Market Size and Forecast by Application
• Market Size and Forecast by End User

Asia-Pacific

• Japanese Market Size and Forecast
• Chinese Market Size and Forecast
• Indian Market Size and Forecast
• Australian Market Size and Forecast
• South Korean Market Size and Forecast
• Rest of Asia-Pacific Market Size and Forecast
• Market Size and Forecast by Product Type
• Market Size and Forecast by Application
• Market Size and Forecast by End User

RoW

• Latin American Market Size and Forecast
• Middle Eastern Market Size and Forecast
• African Market Size and Forecast
• Other Countries Market Size and Forecast
• Market Size and Forecast by Product Type
• Market Size and Forecast by Application
• Market Size and Forecast by End User

Chapter 9 Patent Review

Chapter 10 Competitive Landscape

Overview
Major Players and Market Shares
Porter’s Five Forces Analysis

• Bargaining Power of Suppliers
• Bargaining Power of Buyers
• Threat of New Suppliers
• Threat of Substitutes
• Competitive Rivalry/Degree of Competition

Major Developments

• Mergers and Acquisitions
• New Product Launches and Product Approvals
• Agreements, Collaborations Business Expansions, and Partnerships

Chapter 11 Company Profiles

ADMA BIOLOGICS INC.

• Business Overview
• Products and Services
• Company Financials
• Developments and Strategies

ARTHREX INC.

• Business Overview
• Products and Services

BAXTER INTERNATIONAL

• Business Overview
• Products and Services
• Company Financials

CERUS CORP.

• Business Overview
• Products and Services
• Company Financials

CHINA BIOLOGIC PRODUCTS INC.

• Business Overview
• Products and Services
• Company Financials
• Developments and Strategies

CSL LTD.

• Business Overview
• Products and Services
• Company Financials
• Developments and Strategies

CREAT GROUP

• Business Overview
• Products and Services
• Developments and Strategies

GENERAL ELECTRIC CO.
GRIFOLS INTERNATIONAL SA

• Business Overview
• Products and Services
• Company Financials
• Developments and Strategies

INNOVATIVE RESEARCH

• Business Overview

INTAS PHARMACEUTICALS LTD.

• Business Overview

KEDRION SPA

• Business Overview
• Products and Services
• Company Financials
• Developments and Strategies

LFB SA

• Business Overview

OCTAPHARMA AG

• Business Overview
• Products and Services
• Company Financials
• Developments and Strategies

PRIME BIOLOGICS PTE. LTD.

• Business Overview

SANQUIN

• Business Overview

SHANGHAI RAAS

• Business Overview

SHIRE PLC

• Business Overview
• Products and Services
• Company Financials
• Developments and Strategies

TCS BIOSCIENCES LTD."

List of Tables

Summary Table : Global Market for Blood Plasma Products, by Region, Through 2023
Table 1 : Blood Plasma Components
Table 2 : Percentage of Major Proteins Present in Different Fractions After Cohn’s Fractionation Method
Table 3 : Key Trends in the Global Blood Plasma Market
Table 4 : Global Market for Blood Plasma, by Product Type, Through 2023
Table 5 : Global Market for Immunoglobulins, by Region, Through 2023
Table 6 : Global Market for Immunoglobulins, by Product Subsegment, Through 2023
Table 7 : Global Market for Intravenous Immunoglobulin, by Region, Through 2023
Table 8 : Global Market for Subcutaneous Immunoglobulins, by Region, Through 2023
Table 9 : Global Market for Other Immunoglobulins, by Region, Through 2023
Table 10 : Global Market for Albumins, by Region, Through 2023
Table 11 : Global Market for Coagulation Factor Concentrates, by Region, Through 2023
Table 12 : Global Market for Hyperimmune Globulins, by Region, Through 2023
Table 13 : Protease Inhibitors Used in the Treatment of HIV
Table 14 : Global Market for Other Plasma Fractionation Products, by Region, Through 2023
Table 15 : Global Market for Blood Plasma Products, by Application, Through 2023
Table 16 : Global Market for the Application of Blood Plasma Products in Neurology, by Region, Through 2023
Table 17 : Global Market for the Application of Blood Plasma Products in Immunology, by Region, Through 2023
Table 18 : Global Market for the Application of Blood Plasma Products in Oncology, by Region, Through 2023
Table 19 : Global Market for the Application of Blood Plasma Products in Transplants, by Region, Through 2023
Table 20 : Global Market for the Application of Blood Plasma Products in Hematology, by Region, Through 2023
Table 21 : Global Market for the Application of Blood Plasma Products in Rheumatology, by Region, Through 2023
Table 22 : Global Market for the Application of Blood Plasma Products in Pulmonology, by Region, Through 2023
Table 23 : Global Market for the Application of Blood Plasma Products in Other Areas, by Region, Through 2023
Table 24 : Global Market for Blood Plasma Products, by End User, Through 2023
Table 25 : Global Market for Blood Plasma Products Used in Hospitals and Clinics, by Region, Through 2023
Table 26 : Global Market for Blood Plasma Products Used in Research Laboratories, by Region, Through 2023
Table 27 : Global Market for Blood Plasma Products Used in Academic Institutions, by Region, Through 2023
Table 28 : Global Market for Blood Plasma Products Used in Blood Transfusion Centers, by Region, Through 2023
Table 29 : Global Market for Blood Plasma Products, by Region, Through 2023
Table 30 : North American Market for Blood Plasma Products, by Country, Through 2023
Table 31 : Estimated New Cases of Cancer in the U.S., by Disease Type, 2017
Table 32 : North American Market for Blood Plasma, by Product Type, Through 2023
Table 33 : North American Market for Immunoglobulins, by Type, Through 2023
Table 34 : North American Market for Blood Plasma Products, by Application, Through 2023
Table 35 : North American Market for Blood Plasma Products, by End User, Through 2023
Table 36 : European Market for Blood Plasma Products, by Country, Through 2023
Table 37 : European Market for Blood Plasma, by Product Type, Through 2023
Table 38 : European Market for Immunoglobulins, by Type, Through 2023
Table 39 : European Market for Blood Plasma Products, by Application, Through 2023
Table 40 : European Market for Blood Plasma Products, by End User, Through 2023
Table 41 : Asia-Pacific Market for Blood Plasma Products, by Country, Through 2023
Table 42 : Asia-Pacific Market for Blood Plasma, by Product Type, Through 2023
Table 43 : Asia-Pacific Market for Immunoglobulins, by Type, Through 2023
Table 44 : Asia-Pacific Market for Blood Plasma Products, by Application, Through 2023
Table 45 : Asia-Pacific Market for Blood Plasma Products, by End User, Through 2023
Table 46 : Rest of World Market for Blood Plasma Products, by Country, Through 2023
Table 47 : Estimated Cases of Ebola Deaths in Africa, by Country, 2014-2016
Table 48 : Rest of the World Market for Blood Plasma Products, by Product Type, Through 2023
Table 49 : Rest of World Market for Immunoglobulins, by Type, Through 2023
Table 50 : Rest of World Market for Blood Plasma Products, by Application, Through 2023
Table 51 : Rest of World Market for Blood Plasma Products, by End User, Through 2023
Table 52 : Patents Granted in North America, 2014-2017
Table 53 : Patents Granted in Europe, 2014-2017
Table 54 : Patents Granted in Asia-Pacific, 2014-2017
Table 55 : Patents Granted in the RoW Region, 2014-2016
Table 56 : Porter's Five Forces Analysis
Table 57 : Mergers and Acquisitions
Table 58 : New Product Launches and Product Approvals
Table 59 : Agreements, Collaborations, Business Expansions and Partnerships
Table 60 : ADMA Biologics Inc.: Product Portfolio
Table 61 : ADMA Biologics Inc.: Developments and Strategies
Table 62 : Cerus Corp.: Developments and Strategies
Table 63 : China Biologic Products Inc.: Product Portfolio
Table 64 : China Biologic Products Inc.: Developments and Strategies
Table 65 : CSL Ltd.: Product Portfolio
Table 66 : CSL Ltd.: Developments and Strategies
Table 67 : Creat Group: Product Portfolio
Table 68 : Creat Group: Developments and Strategies
Table 69 : Grifols International SA: Product Portfolio
Table 70 : Grifols International SA: Developments and Strategies
Table 71 : Kedrion SpA: Developments and Strategies
Table 72 : Octapharma AG: Product Portfolio
Table 73 : Octapharma AG: Developments and Strategies
Table 74 : Shire Plc: Product Portfolio
Table 75 : Shire Plc: Developments and Strategies"

 

List of Figures

Summary Figure : Global Market for Blood Plasma Products, by Region, 2017-2023
Figure 1 : Role of Albumin Concentration in Maintaining Osmotic Pressure
Figure 2 : Benefits of Blood Donation to the Donor
Figure 3 : Distribution of Population Aged 65 and Above, by Region, 2015 and 2050
Figure 4 : Blood Donation Globally, 2016 and 2017
Figure 5 : FDA Regulation for Approval of Blood Products and Devices
Figure 6 : Global Market for Blood Plasma, by Product Type, 2017-2023
Figure 7 : Global Blood Plasma Market Share, by Product Type, 2017
Figure 8 : Subsegments of the Market for Immunoglobulin Products
Figure 9 : Global Immunoglobulins Market Share, by Region, 2017
Figure 10 : Global Immunoglobulins Market Share, by Product Subsegment, 2017
Figure 11 : Global Intravenous Immunoglobulin Market Share, by Region, 2017
Figure 12 : Categorization of Subcutaneous Immunoglobulin
Figure 13 : Global Subcutaneous Immunoglobulins Market Share, by Region, 2017
Figure 14 : Global Market Share of Other Immunoglobulins, by Region, 2017
Figure 15 : Global Albumins Market Share, by Region, 2017
Figure 16 : Global Coagulation Factor Concentrates Market Share, by Region, 2017
Figure 17 : Process of the Isolation of Hyperimmune Globulin
Figure 18 : Global Hyperimmune Globulins Market Share, by Region, 2017
Figure 19 : Global Market Share of Other Plasma Fractionation Products, by Region, 2017
Figure 20 : Global Market for Blood Plasma Products, by Application, 2017-2023
Figure 21 : Global Blood Plasma Products Market Share, by Application, 2017
Figure 22 : The Study of Neurology
Figure 23 : Role of Plasma Exchange in the Treatment of Neuroimmunological Disorders
Figure 24 : Functions of the Immune System
Figure 25 : Conditions Engendering Blood Transfusions
Figure 26 : Categories of Bleeding Disorders
Figure 27 : Symptoms of Lupus Infection
Figure 28 : Global Market for Blood Plasma Products, by End User, 2017-2023
Figure 29 : Global Blood Plasma Products Market Share, by End User, 2017
Figure 30 : Role of Platelet-Rich Plasma in Treatment
Figure 31 : Frequent Side Effects Associated with Immunoglobulin Infusions
Figure 32 : Rarely Induced Severe Allergic Reactions Associated with Immunoglobulin Infusions
Figure 33 : Procedure for Plasma Gel Treatment
Figure 34 : Role of Fibrin Sealant in Coagulation Cascade
Figure 35 : Global Market for Blood Plasma Products, by Region, 2017-2023
Figure 36 : Global Blood Plasma Products Market Share, by Region, 2017
Figure 37 : North American Market for Blood Plasma Products, by Country, 2017-2023
Figure 38 : North American Blood Plasma Products Market Share, by Country, 2017
Figure 39 : Distribution of Estimated New Cases of Cancer in the U.S., by Disease Type, 2017
Figure 40 : U.S. Market for Blood Plasma Products, 2017-2023
Figure 41 : Canadian Market for Blood Plasma Products, 2017-2023
Figure 42 : Mexican Market for Blood Plasma Products, 2017-2023
Figure 43 : European Market for Blood Plasma Products, by Country, 2017-2023
Figure 44 : European Blood Plasma Products Market Share, by Country, 2017
Figure 45 : German Market for Blood Plasma Products, 2017-2023
Figure 46 : French Market for Blood Plasma Products, 2017-2023
Figure 47 : Italian Market for Blood Plasma Products, 2017-2023
Figure 48 : Spanish Market for Blood Plasma Products, 2017-2023
Figure 49 : U.K. Market for Blood Plasma Products, 2017-2023
Figure 50 : Rest of European Market for Blood Plasma Products, 2017-2023
Figure 51 : Asia-Pacific Market for Blood Plasma Products, by Country, 2017-2023
Figure 52 : Asia-Pacific Blood Plasma Products Market Share, by Country, 2017
Figure 53 : Japanese Market for Blood Plasma Products, 2017-2023
Figure 54 : Chinese Market for Blood Plasma Products, 2017-2023
Figure 55 : Indian Market for Blood Plasma Products, 2017-2023
Figure 56 : Australian Market for Blood Plasma Products, 2017-2023
Figure 57 : South Korean Market for Blood Plasma Products, 2017-2023
Figure 58 : Rest of Asia-Pacific Market for Blood Plasma Products, 2017-2023
Figure 59 : Rest of World Market for Blood Plasma Products, by Country, 2017-2023
Figure 60 : Rest of World Blood Plasma Products Market Share, by Country, 2017
Figure 61 : Latin American Market for Blood Plasma Products, 2017-2023
Figure 62 : Middle Eastern Market for Blood Plasma Products, 2017-2023
Figure 63 : African Market for Blood Plasma Products, 2017-2023
Figure 64 : Other Countries Market for Blood Plasma Products, 2017-2023
Figure 65 : Global Market Share of Blood Plasma Products, by Company, 2017
Figure 66 : Major Company Development Strategies, 2015-2018
Figure 67 : ADMA Biologics Inc.: Financials, 2015-2017
Figure 68 : ADMA Biologics Inc.: Revenue Share, by Segment, 2017
Figure 69 : Baxter International: Financials, 2015-2017
Figure 70 : Cerus Corp.: Financials, 2015-2017
Figure 71 : China Biologic Products Inc.: Financials, 2015-2017
Figure 72 : CSL Ltd.: Financials, 2015-2017
Figure 73 : Grifols International SA: Financials, 2015-2017
Figure 74 : Kedrion SpA: Financials, 2015-2017
Figure 75 : Kedrion SpA: Revenue Share, by Segment, 2017
Figure 76 : Octapharma AG: Financials, 2015-2017
Figure 77 : Shire Plc: Financials, 2015-2017
Figure 78 : Shire Plc: Revenue Share, by Segment, 2017

当レポートのプレスリリースは発行されておりません。